Genmab gets EPKINLY FDA approval for diffuse large B-cell lymphoma

Danish biotech company Genmab has secured accelerated approval for EPKINLY (epcoritamab-bysp) from the US Food and Drug Administration (FDA) for the treatment of relapsed or ... Read More